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Evaluation of Gianturco Coils for Closure of Large (>23.5 mm) Patent
Ductus Arteriosus
CARL Y. OWADA, MD, DAVID F. TEITEL, MD, PHILLIP MOORE, MD
San Francisco, California
Objectives. This report evaluates the use of Gianturco coils to
close large patent ductus arteriosus (PDAs) (>23.5 mm) and
describes transvenous delivery of 0.052-in. (0.132-cm) Gianturco
coils.
Background. Coil closure of PDAs has become increasingly
popular. However, the technique has significant limitations when
used to close large PDAs. This report evaluates patient charac-
teristics, PDA anatomy, hemodynamic variables, delivery tech-
nique and coil geometry to determine predictors of success.
Methods. Between January 1995 and January 1997, 16 of 118
patients undergoing catheterization for PDA closure were found
to have large PDAs. Their median age and weight were 14 months
(range 3 months to 43 years) and 8.5 kg (range 3.5 to 73),
respectively. The mean PDA diameter was 4.3 mm (range 3.5 to
5.9). Closure of PDAs was attempted using transcatheter delivery
of 0.038-in. (0.096-cm) and 0.052-in. coils. Differences in clinical,
anatomic, hemodynamic and technical variables between suc-
cesses and failures were compared.
Results. Eleven (69%) of 16 patients had successful closure of
their PDA. Failures occurred only in patients <8 months of age
with an indexed PDA diameter >7 mm/m and a pulmonary/
systemic flow ratio >22.8:1. Use of 0.052-in. coils tended to reduce
the incidence of embolization and the number of coils needed for
closure.
Conclusions. Patients >8 months of age can have successful
closure of large PDAs with currently available Gianturco coils.
The 0.052-in. Gianturco coils can be used safely to close large
PDAs in infants as small as 6 kg. Increased experience and
improved coil design may improve closure rates of large PDAs in
infants.
(J Am Coll Cardiol 1997;30:1856–62)
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Since the introduction of nonsurgical closure of patent ductus
arteriosus (PDA) by Portsmann et al. in 1967 (1,2) several
ductal occlusion devices have been developed (3–8). Cur-
rently, the only device available for use throughout the United
States is the Gianturco coil. Closing PDAs with Gianturco coils
has become increasingly popular owing to the small sheath
requirements, relative ease of delivery, high rate of successful
occlusion, low rate of complications and low cost. However,
despite various modifications of delivery techniques, successful
closure has been limited to small- to moderate-sized PDAs
(6,9–13). Large PDAs ($3.5 mm in diameter) have been
successfully closed nonsurgically using the Rashkind, Clam-
shell and button devices, although these devices remain inves-
tigational in the United States (14). This report evaluates the
use of Gianturco coils for closure of large PDAs and describes
our preliminary experience using transvenous delivery of
0.052-in. (0.132-cm) thick Gianturco coils. We compare patient
characteristics, PDA anatomy, hemodynamic variables, deliv-
ery technique and coil geometry to determine predictors of
success.
Methods
Patients. Of the 118 patients selected for PDA closure
between January 1995 and January 1997, 16 had a patent
ductus $3.5 mm in minimal diameter and constituted the study
group. Their ages ranged from 3 months to 43 years (median
14 months). Five patients were ,6 months of age. Their
weights ranged from 3.5 to 73 kg (median 8.5) (Table 1). All 16
patients had attempted closure of an isolated PDA. Three had
Down syndrome. Two had moderate pulmonary hypertension.
Five had cardiorespiratory symptoms. All had echocardio-
graphic findings of a large PDA, including a left atrium to
aortic root dimension (LA/Ao) ratio .1.3 and an estimated
PDA size of $3 mm by color flow mapping. All families gave
written consent before the procedure.
Procedure. After hemodynamic catheterization, a descend-
ing aortogram was obtained. Ductal dimension was measured
in the magnified lateral projection using the angiographic
catheter as a reference. Quantitative angiographic assessment
of shunt severity was a modification of that described by Lloyd
et al. (9). To the four categories of angiographic shunt (trace,
small, moderate and large) we added a fifth category of a trivial
shunt, defined as opacification of the juxtaductal area, giving a
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“smoky appearance” to the coil in the pulmonary artery (PA)
that was slow to clear. Cefazolin (20 to 40 mg/kg body weight)
was administered intravenously before coil delivery.
Twenty minutes after coil delivery a descending aortogram
and right-sided saturation and pressure measurements were
repeated. Patients who had successful closure of their PDA
received two additional doses of cefazolin. Echocardiography
was performed 1 to 5 h after catheterization to evaluate for
flow disturbance in the left pulmonary artery (LPA) or de-
scending aorta (DAo) and for evidence of a residual shunt.
Transvenous coil closure. Transvenous coil closure using
0.038-in. (0.096-cm) Gianturco coils (Cook Inc.) was per-
formed as described by Hijazi and Geggel (11). Transvenous
coil closure using 0.052-in. Gianturco coils (Cook Inc.) was
performed using a coaxial system consisting of a hand-shaped
6F guiding catheter (Omniguide, MIS) over a 4F Berenstein
catheter (MediTech). The system was advanced through a
6F femoral venous sheath anterogradely over a 0.025-in.
(0.063-cm) exchange length Amplatz guide wire (Cook Inc.)
across the PDA into the DAo. The guide wire and Berenstein
catheter were removed and the guiding catheter tip was
positioned in the aorta at the mouth of the ductal ampulla. The
diameter of the coil was at least 1.7 times the minimal PDA
diameter and the coil was long enough to produce at least
three complete loops. The coil was advanced through the
guiding catheter using the soft end of a 0.052-in. guide wire
(Cook Inc.). Under fluoroscopic guidance at least 21⁄4 loops of
coil (up to 31⁄4 loops for the longer coils) were advanced out of
the catheter in the DAo. The entire system was then brought
back into the ductal ampulla. Correct position was confirmed
using a reference image of the lateral descending aortogram.
The guiding catheter was then withdrawn over the wire into the
main pulmonary artery (MPA) delivering the final 3⁄4 loop of
coil on the PA side of the ductus (Fig. 1). Additional 0.038-in.
or 0.035-in. (0.089-cm) coils were placed by transvenous or
transarterial approach to complete closure as necessary.
Transarterial coil closure. Transarterial coil closure of the
PDA using 0.035-in. and 0.038-in. coils was performed as
previously described using either a 4F or 5F Bentson or
Berenstein catheter (MediTech) (6).
Abbreviations and Acronyms
BSA 5 body surface area
DAo 5 descending aorta
LA/Ao 5 left atrial/aortic root dimension ratio
LPA 5 left pulmonary artery
MPA 5 main pulmonary artery
PA 5 pulmonary artery
PDA 5 patent ductus arteriosus
Qp/Qs 5 pulmonary/systemic flow ratio
Table 1. Clinical, Anatomic and Hemodynamic Characteristics of 16 Patients With Large Patent Ductus Arteriosus
Patient
No.
Clinical Anatomic Hemodynamic
Age
(yr)
Weight
(kg)
Clinical
Score
PDA
(mm)
PDA/BSA1/2
(mm/m) PDA/DAo
Amp/BSA1/2
(mm/m)
L/BSA1/2
(mm/m) LA/Ao Qp/Qs
Diastolic Gradient
(mm Hg)
Successful closure 1 3.24 12.7 3 4.6 6.2 0.44 16.0 7.4 1.4 1.9 2
2 7.41 20.0 0 3.8 4.3 0.34 15.2 13.4 2.0 1.2 58
3 2.73 12.5 1 4.3 5.7 0.40 16.0 8.0 2.3 1.8 8
4 1.32 8.4 3 4.0 6.4 0.47 19.2 12.7 1.6 2.1 14
5 43.35 73.0 1 5.1 3.9 0.28 14.6 7.3 1.4 41
6 3.76 19.3 1 4.3 5.0 0.35 16.0 4.0 1.5 1.7 39
7 0.32 6.2 1 4.2 7.5 0.52 19.9 9.4 1.8 3.3 18
8 1.61 10.0 2 3.9 5.7 0.36 18.5 10.1 1.9 3.4 23
9 0.94 8.6 1 3.6 5.7 0.37 12.9 12.8 1.7 1.9 38
10 2.44 10.4 1 3.5 5.1 0.39 18.1 9.0 1.7 1.3 38
11 0.58 6.8 3 4.5 7.7 0.50 17.9 14.6 1.5 3.7 11
Median 2.44* 10.4* 1* 4.2 5.7* 0.39* 16.0 9.4 1.7 1.9* 23
Failed closure 12 0.43 3.5 3 4.8 10.2 0.83 15.9 14.2 2.7 2.8 8
13 0.48 7.0 3 4.0 6.9 0.44 15.1 8.2 1.9 3.5 13
14 0.68 7.0 3 4.1 7.0 0.51 19.8 12.2 2.0 3.1 11
15 0.50 5.5 3 5.9 10.7 0.79 19.8 13.8 1.9 3.9 3
16 0.24 5.7 4 4.0 7.5 0.44 20.0 11.8 1.4 2.8 18
Median 0.48 5.7 3 4.1 7.5 0.51 19.8 12.2 1.9 3.1 11
*p , 0.05—successful and failed group differences were compared using the Mann-Whitney rank-sum test. Amp 5 ductal ampulla diameter; BSA 5 body surface
area; Clinical Score 5 the sum of clinical characteristics: cardiorespiratory symptoms, bounding pulse, active precordium and pulse pressure .45 mm Hg, with each
characteristic assigned 1 point; DAo 5 descending aorta; Diastolic Gradient 5 aortopulmonary pressure gradient measured in diastole; L 5 ampulla length; LA/Ao 5
left atrial/aortic root length ratio; LPA 5 left pulmonary artery; PDA 5 minimal diameter of the patent ductus arteriosus measured in diastole; Qp/Qs 5
pulmonary/systemic flow ratio.
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Coil retrieval. All embolized coils, those which spontane-
ously migrated to the PA, and malpositioned coils, those
thought to have improper position with protrusion into the
LPA or aorta, were retrieved through either the ipsilateral or
contralateral femoral vein using a 6F to 8F Mullins sheath
(Cook Inc.), 5F Bentson or Berenstein catheter and a 5- or
10-mm Nitnol snare (Micro Vena). Retrievals of 0.052-in. coils
were accomplished through a 7F long sheath.
Analysis. Patients were retrospectively divided into suc-
cessful (defined as no residual shunt detected by hemoximeter
measurement and less than or equal to trace residual angio-
graphic shunt) and failed closures (defined as greater than
trace residual angiographic shunt). Patient characteristics,
PDA anatomy, hemodynamic variables, delivery technique and
coil geometry were compared between the two groups. Patient
characteristics included age, weight and a clinical score (Table
1). The clinical score was derived by adding one point for each
clinical finding that suggested a large PDA, including cardio-
respiratory symptoms (tachypnea, diaphoresis, exercise intol-
erance, feeding difficulty or growth failure), bounding pulses,
hyperactive precordium or a pulse pressure .45 mm Hg.
Anatomic dimensions of the PDA included minimal PDA
diameter in systole and diastole, length of the PDA and
diameters of the LPA, ampulla and DAo at the level of the
diaphragm. To adjust for patient size, each dimension was
indexed by dividing by the square root of the body surface area
(BSA) (15,16). This indexing procedure produced relative
LPA and DAo dimensions that were similar in all patients
irrespective of their BSA. Hemodynamic variables were quan-
tified by determining the echocardiographic LA/Ao ratio,
aortopulmonary diastolic gradient, pulmonary to systemic flow
ratio (Qp/Qs) and degree of angiographic shunt.
Delivery technique of the primary coil was designated as
either transvenous or transarterial. Variables of coil geometry
included the ratio of coil helical diameter to PDA diameter,
wire gauge, the ratio of wire gauge to helical diameter (an
index of coil stiffness) and the need for additional coils as it
related to the wire gauge of the primary occluding coil. The
geometries of coils that were properly positioned were com-
pared to those of coils that embolized or were malpositioned
and required retrieval.
Statistical analysis. Minimal PDA diameter is expressed as
mean value 6 SD. Because of the skewed distribution, unequal
variance and small sample size, differences of each variable
between successes and failures were quantified using the
Mann-Whitney rank-sum test. To determine the degree of
correlation between patient age versus clinical score and
PDA/DAo ratio versus Qp/Qs, we performed a Spearman rank
correlation analysis. Differences between minimal PDA diam-
eter in systole and diastole were evaluated using the paired t
test. Statistical significance was achieved at p # 0.05.
Results
Patients and procedure. We found that all patients with
large PDAs had moderate to large shunts by angiographic
scoring. Overall, the minimal PDA diameter ranged between
3.5 and 5.9 mm (mean 4.3 6 0.6) (Table 1). The differences in
PDA diameter measured in systole compared with diastole did
not achieve statistical significance (p 5 0.5). Transvenous
delivery of the primary coil was performed in 11 of 16 patients,
whereas the remainder had transarterial coil delivery. A
0.052-in. coil was the primary coil in 10 patients, with an
0.038-in. coil the primary coil in the remaining six patients. All
patients were discharged within 24 h of the procedure or had
their PDA surgically ligated the next day.
Figure 1. Sequential digital cine frames showing the delivery of a
0.052-in., 10-cm long, 8-mm helical diameter coil. A, Lateral angiogram
demonstrates a large 4.5-mm PDA in a 6.8-kg infant. B, Two and
one-quarter loops of coil have been advanced into the DAo adjacent to
the ductal ampulla through a 6F guiding catheter. C, The coil
completely delivered has three and one-quarter loops stacked along
the inferior margin of the ductal ampulla and the remaining three-
quarter loop on the PA side. A 0.035-in., 5-cm long, 5-mm helical
diameter coil has been delivered over the superior margin of the
primary coil to complete closure.
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Successes. Eleven (69%) of 16 patients had successful
closure of large PDAs using one to four Gianturco coils (Table
2). No patient had evidence of a residual shunt by the Fick
technique immediately after coil placement. Eight patients had
no audible murmur after the procedure: four of them had no
angiographic shunt, two had a trivial shunt and one had a trace
residual angiographic shunt. A postcoil aortogram was not
obtained in one patient. Echocardiographic follow-up of these
eight patients 1 to 5 h after the procedure showed no residual
shunt. Three patients had a soft residual systolic murmur in
association with a trivial to trace residual angiographic shunt.
These small shunts were seen to persist on echocardiographic
follow-up 1 to 24 h after ductal closure.
Failures. There were five patients in whom coil closure was
not successful. Three patients had embolization in the setting
of a coil helical diameter less than twice the minimal PDA
diameter. Larger coils were not used owing to the small aortic
dimensions of the patients. In the fourth patient, embolization
occurred despite a helical diameter greater than twice the
minimal PDA diameter. In this patient the PDA measured
4.0 mm. A well positioned 0.038-in., 10-cm long, 10-mm helical
diameter coil embolized to the right pulmonary artery. Simul-
taneous delivery of a 0.038-in., 8-cm long, 8-mm helical
diameter coil anterograde and a 0.038-in., 5-cm long, 5-mm
helical diameter coil retrograde stayed in place for ,1 min
before embolizing to the LPA. A final attempt at closure using
the snare technique (12) was unsuccessful. In the final patient
failure was due to coil impingement on the proximal LPA. This
patient had complete closure of a 4.0-mm PDA using a
combination of a 0.052-in., 8-cm long, 8-mm helical diameter
and 0.035-in., 5-cm long, 5-mm helical diameter coil. Despite
good positioning with only one loop on the PA side, the coils
caused mild LPA stenosis with a peak systolic gradient
20 mm Hg. This result was thought to be unacceptable, so the
coils were removed. All five patients were referred for surgical
ligation of their PDAs.
Success versus failure group comparisons. To better un-
derstand the limitations of the current method of ductal
closure, we compared the characteristics of the two groups.
Patients with failed closure were significantly younger (median
age 5 months 3 weeks vs. 2 years 5 months, p , 0.05) and
smaller (median weight 5.7 kg vs. 10.4 kg, p , 0.01) (Table 1).
The clinical scores of failures were higher (p , 0.02), suggest-
ing a greater hemodynamic effect of the PDA in the failure
group, despite similar minimal PDA diameters between groups
(mean 4.2 6 0.5 mm vs. 4.6 6 0.8 mm, p . 0.2). This apparent
discrepancy is easily explained by covariance of patient age
with clinical score (p 5 0.016). Failures had a significantly
larger indexed minimal PDA diameter compared with suc-
cesses (p , 0.01) and a significantly larger PDA/DAo ratio
(median 0.51 vs. 0.39, p , 0.05). In contrast, there was no
difference in the indexed ampulla diameter or PDA length,
suggesting the shape of the ducts were similar in both groups.
Although there were no differences in the LA/Ao ratio or pulse
pressure (p . 0.2) between the groups, failures had a signifi-
cantly larger Qp/Qs (median 3.1 vs. 1.9, p , 0.05) and a
suggestion of lower diastolic gradients between the DAo and
PA (median 11 mm Hg vs. 23 mm Hg, p 5 0.09). As expected,
Qp/Qs correlated well with the PDA/DAo ratio (p , 0.01).
Although differences regarding the method of coil delivery
or coil geometry did not achieve significance, certain trends
were observed. We found a need for fewer coils to close large
PDAs when a 0.052-in. coil was the primary coil (average 1.7
coils per patient with a 0.052-in. coil vs. 2.5 coils per patient
with a 0.038-in. coil) (Fig. 2). Furthermore, there tended to be
a lower rate of embolization or malposition when 0.052-in.
Table 2. Procedural Characteristics and Results
Patient
No.
Primary Coil
No. of Additional
Coils for Closure
Shunt†
No. of
Malpositioned
Coils
No. of
Embolized
Coils
Maximal Size
of Embolized
Coil*
Delivery
Route
Coil
Size* Before After
24-h Echocardiographic
Follow-Up
1 A 0.038-10-10 2 Large Trace None — —
2 A 0.038-8-8 2 Moderate Trivial None — 1 0.038-5-5
3 A 0.038-8-8 2 Large Trivial Trivial 3 3 0.038-8-8
4 V 0.052-9-9 1 Large Trivial None — 4 0.038-8-8
5 V 0.052-12-12 0 Large None — —
6 V 0.052-8-8 1 Moderate None None — —
7 V 0.052-8-8 0 Large Trace Small — —
8 V 0.052-9-9 3 Large Trace Small 1 —
9 V 0.052-10-8 1 Large None None — —
10 A 0.038-8-6 0 Moderate None None — —
11 V 0.052-10-8 1 Moderate None — —
12 V 0.038-5-5 Large Operation None — 1 0.038-5-5
13 A 0.038-8-8 Large Operation None — 5 0.038-10-10
14 V 0.038-8-8 Large Operation None — 3 0.052-8-8
15 V 0.052-10-10 Large Operation None — 1 0.052-10-10
16 V 0.052-8-8 Moderate Operation Trivial 2 —
*Wire gauge (in.)-length (cm)-helical diameter (mm). †The shunt “before” and “after” was determined by angiography; shunt at “follow-up” was determined by
echocardiography. A 5 transarterial; V 5 transvenous.
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primary coils were used (0.6 coils per patient with a 0.052-in.
coil vs. 2.4 coils per patient with an 0.038-in. coil). For example,
failure in Patient 13 resulted from repeated embolization of
0.038-in. coils (five total), despite a helical diameter of 2.5
times the PDA diameter. In contrast, Patient 11, who had a
similar sized PDA and shunt, had successful closure with a
0.052-in., 10-cm long, 8-mm helical diameter coil with a helical
diameter ,1.8 times the PDA diameter.
Complications. Complications were minimal with no in-
stance of diminished femoral pulse or color flow disturbance in
the DAo. None of the coils embolized to the DAo. All
embolized or malpositioned coils were retrieved successfully
(Table 2). Three patients showed mild color flow disturbance
or increased flow velocity in the LPA. Two of these patients
had multiple 0.038-in. coils placed in their PDAs (Fig. 2). The
third patient, an 11-month old with a 3.6-mm PDA, had a
0.052-in., 10-cm long, 8-mm helical diameter coil delivered
with one and one-half loops on the PA side. The distal coil
loop could be seen near the LPA orifice. Pressure pullback
measurement demonstrated a 14-mm Hg gradient across the
proximal LPA; Doppler velocity was 2.5 m/s. One patient
received a red blood cell transfusion to correct for exacerba-
tion of physiologic anemia (hematocrit change from 27% to
24%).
Discussion
Successful closure of PDAs .3.5 mm in diameter can be
achieved in nearly 70% (confidence interval 46% to 92%) of all
patients using currently available Gianturco coils. We had no
failures in patients .8 months of age. There tended to be a
higher incidence of failure when a 0.038-in. coil was used as the
primary occluding coil. Large 0.052-in. coils can be used safely
and effectively to close large PDAs in infants as small as 6 kg
(Fig. 3). Anatomic, hemodynamic and technical factors (deliv-
ery method and coil geometry) influence success.
Anatomic factors. Anatomic factors that may influence
success include PDA size, PDA shape and the size of contig-
uous structures relative to the ductus. In our experience,
neither absolute PDA diameter nor PDA shape influenced
success. Only relative PDA size (indexed PDA diameter and
PDA/DAo ratio) was important. This suggests that the size of
the patient and DAo are the limiting factors of success with
currently available coils. Modifications of delivery technique
and coil design are needed to overcome these size limitations.
Hemodynamic factors. A hemodynamic effect that may
influence success is the degree of left to right shunt. The force
exerted on a coil from a large shunt may promote emboliza-
tion. In support of this notion, the failure group had signifi-
cantly larger shunts than the successful group. Shunt size is
obviously not independent of anatomic factors, and, as ex-
pected, the largest shunts occurred in patients with relatively
large PDAs. Inherent to the technique of using currently
available coils for closure of large PDAs is a significant
incidence of residual shunt, and therefore the presence of
shear force that could promote embolization, during and after
initial coil placement. Modifications in technique and coil
design to ensure immediate, complete closure with a single coil
Figure 2. Comparison of 0.038-in.
coils with a 0.052-in. coil to close
similar sized PDAs. A, Lateral angio-
gram from Patient 1 after transarte-
rial placement of three coils (0.038
in., 10 cm long, 10-mm helical di-
ameter; 8 cm long, 8-mm helical
diameter; 5 cm long, 5-mm helical
diameter) shows a trace residual
shunt that spontaneously closed
within 3 h of the procedure. B, Lat-
eral angiogram from Patient 6 after
transvenous placement of a 0.052-
in., 8-cm long, 8-mm helical diame-
ter coil and transarterial placement
of a 0.035-in., 4-cm long, 4-mm he-
lical diameter coil. Contrast injec-
tion shows no residual shunt.
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should significantly reduce the embolization rate associated
with large left to right shunts.
Technical factors. Technical factors that may influence
success include delivery method, coil positioning and coil
geometry. We found no difference in the success rate between
the transarterial or transvenous method of coil delivery. How-
ever, there may be theoretic advantages of transvenous deliv-
ery in large PDAs. First, the use of an arterial sheath in small
infants poses some risk for pulse loss. Second, transvenous
delivery allows the coil to form completely before being pulled
into the ductal ampulla. Our impression is that this optimizes
apposition to the ampulla wall and leads to more immediate,
complete closure. This contrasts with transarterial delivery,
where the coil springs into the ductal ampulla, creating an
additional left to right force, additive with shunt flow, which
may encourage embolization. Such a force may be com-
pounded when using the stiffer 0.052-in. coils. For these
reasons, we recommend the transvenous method for delivery
of 0.052-in. coils.
Coil geometry. Another technical factor, coil size, which
consists of wire gauge, length and helical diameter, may
influence the success of ductal closure. Lloyd et al. (9) recom-
mend using 0.038-in. coils with a helical diameter at least twice
that of the minimal PDA diameter and length enough to form
three complete loops. Following these guidelines, we have
found the need for placing multiple coils (three to five coils) to
occlude large PDAs, which increase procedure time, risk of
LPA stenosis and risk of embolization (Fig. 2). In addition,
0.038-in. coils have embolized in the setting of large left to
right shunts despite optimal helical diameter and delivery
position. This has led us to use 0.052-in. coils to close large
PDAs. These larger, stiffer coils have a greater stability in
PDAs with large shunts, allowing us to successfully use a
helical/minimal PDA diameter ratio as low as 1.7:1 with a trend
toward less incidence of embolization. We also found a trend
toward needing fewer coils for complete closure.
The geometry of the 0.052-in. coil in the PDA and the
location of residual shunts, when present along the superior
margin, suggest that placement of more loops of coil in the
ductal ampulla may effect closure with a single coil. These
stiffer coils tend to form a tight stack within the ductal ampulla,
aligning along the inferior edge, without protruding into the
aorta (Fig. 1, B and C; Fig. 2B; and Fig. 3B). Because the true
wire thickness of a 0.052-in. coil is 1.1 mm, it stands to reason
that to occlude a 4-mm PDA with a single coil, four complete
loops are needed in the ampulla. Thus, with a minimum of
one-half loop on the PA side, the coil length required to
completely close a 4-mm ductus using a 0.052-in., 8-mm
diameter coil would be 12 cm.
Longer coils that ensure the height of the ductal ampulla
coil stack to be equal to the PDA diameter may allow for
further reduction in the minimal helical diameter necessary to
prevent embolization. For example, an 0.052-in., 10-cm long,
8-mm helical diameter coil was used to successfully close a
4.5-mm PDA with a Qp/Qs of 3.7:1. Despite inadequate length
to form four complete loops in the ductal ampulla, a coil to
PDA diameter ratio ,1.8:1 and a residual shunt after delivery,
the coil did not embolize (Fig. 1). The residual shunt along the
superior margin was closed with one additional coil. These
considerations may ultimately minimize coil protrusion into
the DAo and LPA and may in turn overcome the anatomic
limitations seen in small infants.
Study limitations. Limitations of this study include patient
variability within a small sample size, covariance and retrospec-
tive study design. The variability in patient age and size forced
a nonparametric method of data analysis with only 65% power
to detect differences between successes and failures. Further-
more, this analysis assumes that each variable tested is inde-
pendent. The variables examined, however, are not entirely
independent, with patient age varying linearly with clinical
score and relative PDA size varying with degree of hemody-
namic shunt. Because covariance is not accounted for in this
statistical model, results should be interpreted with caution.
Finally, this retrospective review introduces biases imposed by
variables that cannot be controlled. These variables include an
operator learning curve, trend over time toward the use of
0.052-in. coils as the primary coil and operator differences in
delivery technique. Fourteen of the 16 patients had the proce-
dure performed by one of the authors (P.M.), thus minimizing
operator differences.
Conclusions. Successful closure of large PDAs can be
achieved in almost 70% of patients and, in our experience,
Figure 3. A, Lateral angiogram from Patient 7, who weighed 6.2 kg,
shows a 4.2-mm PDA. B, Contrast injection through a 4F Bentson
catheter demonstrates the 0.052-in., 8-cm long, 8-mm helical diameter
coil to be well placed in the ductal ampulla with a trace residual shunt.
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100% (confidence interval 66% to 100%) of patients .8 months
of age using standard delivery techniques of currently available
Gianturco coils. Our preliminary experience suggests that 0.052-
in. coils can be used safely to close large PDAs in infants as small
as 6.2 kg. Closure failures occurred in patients ,8 months of age
with an indexed PDA diameter .7 mm/m and a Qp/Qs $2.8. The
stiffer characteristic of 0.052-in. coils may offer advantages over
0.038-in. coils for the closure of PDAs with large shunts. Longer
coil lengths may improve the closure rate and allow a smaller
helical to minimal PDA diameter ratio to be used. Increased
experience with 0.052-in. coils and improved coil design may
improve the rate of large PDA closure in infants.
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